The November/December 2009 edition of Health Affairs focuses on key global health challenges, including tackling so-called “neglected diseases” such as trachoma, the leading cause of preventable blindness worldwide.  Key lawmakers, leading health policy experts, including former NIH Director Elias Zerhouni, M.D.; and industry officials have been invited to discuss the appropriate strategies and policies for fighting neglected diseases at a November 3 Health Affairs briefing.

WHEN:      9:00 a.m. – 12:30 p.m.
                    Tuesday, November 3, 2009
WHERE:   Capital Hilton Hotel
                    1001 16th St., NW (northeast corner of 16th and K), Washington, D.C.
                    Presidential Ballroom, Mezzanine
                    Metro: Farragut North (Red Line); Farragut West (Blue & Orange Lines)
RSVP:        RSVP for this event online.

Among the topics to be addressed:

• What are neglected diseases and what has worked to help eliminate them and what has fallen short?
• How can public/private partnerships help to control or eliminate these diseases?
• What tax and public policies, research and industry relationships are critical in the fight against neglected diseases?


In the past 20 years, HIV/AIDS, malaria, and tuberculosis have occupied the global health spotlight. At the same time, hundreds of millions of people around the world die or are sickened by a class of infectious diseases often referred to as “neglected” tropical diseases.  Today, more than 30 diseases caused by worms, protozoa, bacteria, fungi or viruses afflict the poorest people in the poorest countries, and collectively cause as much burden as does malaria or AIDS.

As scientists, health experts, and policymakers learn more about the health and economic toll conditions such as schistosomiasis or dengue fever impose on nations, many experts want U.S. policymakers to be fostering more creative public-private partnerships to develop treatments and distribute interventions that would conquer or control these conditions.

The briefing is sponsored by Global Health Progress, an initiative sponsored by the Pharmaceutical Research and Manufacturers of America.

Health Affairs will offer live updates from the event on Twitter at #HAdiseases

Tags: Global Health